TELA Bio, Inc.
TELA· Nasdaq
TELATELA Bio, Inc.
Filed Mar 25, 2021 · 10-K · 84 days after period end · 0001558370-21-003483
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|
| Revenue | $5.67M | $4.86M | — |
| Net Income | -$7.79M | -$6.53M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TELA Bio, Inc. · CIK 1561921 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 25, 2021 · 84 d after period end
